Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer

NCT01164150 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT01164150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01164150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer
Lead sponsor
Cancer Trials Ireland
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2010
Completion date
March 13, 2020
Enrollment
92 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, gastrointestinal complications, radiation toxicity, urinary complications